Graves Disease
Conditions
Interventions
The control group:placebo + methimazole
The test group:Jiakangtongzhi Formulation + methimazole
Sponsors
Guang 'anmen Hospital, Chinese Academy of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: ? Meet the diagnostic criteria of graves disease in western medicine ; ? Meet the diagnostic criteria of TCM syndrome; ? Aged between 18 and 65 years, and gender is not limited; ? Informed consent has been signed.
Exclusion criteria
Exclusion criteria: ?Pregnant and lactating women and those are planing for pregnancy in the near future; ? Patients with severe primary diseases such as cardiovascular and cerebrovascular vessels, liver, kidney, and hematopoietic system, or cancer and mental illness; ?Patients with hyperthyroidism crisis; ?Patients with exophthalmus infiltrative; ?Allergic constitution or allergic history to multiple drugs; l? Patients treated with either isotope or surgery; ? Patients who have participated in the clinical studies of other drugs in the past one month; ? Those who are not fully understood and unwilling to participate in this study, or who reduce the possibility of enrollment or poor compliance, such as unstable work and living place, according to the judgment of the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Thyroid function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurernce rate;Heart rate;Degree of goiter;Exophthalmus;The reduction of methimazole;Anti-TSHR;aTPO;aTG; | — |
Countries
China
Contacts
Public ContactQing Ni
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed